Work

Pooled safety summary for patients treated with the CD22-directed cytotoxin moxetumomab pasudotox-tdfk.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.7014

Authors: Robert J. Kreitman, Steven Coutre, Cynthia Elesinmogun, Nataliya Kuptsova-Clarkson, Xia Li, Ira Pastan, Douglas Edward Gladstone

Institutions: National Institutes of Health, National Cancer Institute, Stanford Medicine, Stanford University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2961686248

Cites:

Cited by:

Related to: 10